Nothing Special   »   [go: up one dir, main page]

EA201691011A1 - Последовательность модифицированного эндолизина el188 - Google Patents

Последовательность модифицированного эндолизина el188

Info

Publication number
EA201691011A1
EA201691011A1 EA201691011A EA201691011A EA201691011A1 EA 201691011 A1 EA201691011 A1 EA 201691011A1 EA 201691011 A EA201691011 A EA 201691011A EA 201691011 A EA201691011 A EA 201691011A EA 201691011 A1 EA201691011 A1 EA 201691011A1
Authority
EA
Eurasian Patent Office
Prior art keywords
polypeptides
nucleic acids
sequence
relates
endolysine
Prior art date
Application number
EA201691011A
Other languages
English (en)
Inventor
Ирина Аносова
Original Assignee
Лисандо Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лисандо Аг filed Critical Лисандо Аг
Publication of EA201691011A1 publication Critical patent/EA201691011A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01017—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Заявленное изобретение относится к полипептидам, содержащим аминокислотную последовательность, демонстрирующую как минимум примерно 90% идентичность с последовательностью SEQ ID NO: 1. Упомянутые полипептиды предпочтительно расщепляют пептидогликан грамотрицательных бактерий, в частности бактерий Pseudomonas и/или Campylobacter. Дополнительно заявленное изобретение относится к нуклеиновым кислотам, кодирующим упомянутые полипептиды, векторам, включающим упомянутые нуклеиновые кислоты, и соответствующим клеткам-хозяинам. И, наконец, заявленное изобретение относится к композициям, содержащим упомянутые полипептиды, нуклеиновые кислоты, векторы и/или клетки-хозяины, согласно заявленному изобретению.
EA201691011A 2013-11-14 2014-11-14 Последовательность модифицированного эндолизина el188 EA201691011A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/EP2013/073872 WO2015070912A1 (en) 2013-11-14 2013-11-14 Modified el188 endolysin sequence
PCT/EP2014/074678 WO2015071437A1 (en) 2013-11-14 2014-11-14 Modified el188 endolysin sequence

Publications (1)

Publication Number Publication Date
EA201691011A1 true EA201691011A1 (ru) 2017-02-28

Family

ID=49584734

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201691011A EA201691011A1 (ru) 2013-11-14 2014-11-14 Последовательность модифицированного эндолизина el188

Country Status (8)

Country Link
US (1) US10167462B2 (ru)
KR (1) KR20160079116A (ru)
CN (1) CN105793420A (ru)
AU (1) AU2014350105A1 (ru)
BR (1) BR112016011095A2 (ru)
CA (1) CA2929692A1 (ru)
EA (1) EA201691011A1 (ru)
WO (2) WO2015070912A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017028413A2 (pt) * 2015-07-02 2018-08-28 Dana Farber Cancer Inst Inc peptídeos antimicrobianos estabilizados
RU2724545C2 (ru) 2015-09-17 2020-06-23 Контрафект Корпорейшн Полипептиды лизина, активные против грамотрицательных бактерий
CN109069578A (zh) 2016-02-29 2018-12-21 达纳-法伯癌症研究所股份有限公司 用于治疗感染的钉合的细胞内靶向抗微生物肽
WO2018185634A1 (en) * 2017-04-03 2018-10-11 Sasinapas Co., Ltd. Engineered gram-negative endolysins
US11325955B2 (en) 2017-07-19 2022-05-10 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
AU2018384790B2 (en) 2017-12-12 2024-10-17 Contrafect Corporation Identification of lysins and derivatives thereof with bacterial activity against pseudomonas aeruginosa
EP3727451B1 (en) * 2017-12-22 2023-05-10 The Rockefeller University Recombinant pseudomonas aeruginosa lysins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0815484D0 (en) 2008-08-26 2008-10-01 Univ Leuven Kath Antibacterial agents
KR101701890B1 (ko) 2009-06-26 2017-02-02 뤼산도 아게 항균제
AU2010264656B2 (en) * 2009-06-26 2016-01-21 Katholieke Universiteit Leuven, K.U. Leuven R&D Antimicrobial agents
TWI527521B (zh) * 2010-04-27 2016-04-01 利山鐸公司 減少生物膜的方法
EP2468856A1 (en) * 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents

Also Published As

Publication number Publication date
CA2929692A1 (en) 2015-05-21
WO2015070912A1 (en) 2015-05-21
AU2014350105A1 (en) 2016-05-12
US10167462B2 (en) 2019-01-01
CN105793420A (zh) 2016-07-20
BR112016011095A2 (pt) 2017-09-19
US20160298101A1 (en) 2016-10-13
WO2015071437A1 (en) 2015-05-21
KR20160079116A (ko) 2016-07-05

Similar Documents

Publication Publication Date Title
EA201691011A1 (ru) Последовательность модифицированного эндолизина el188
GB2569733A (en) RNA-guided nucleic acid modifying enzymes and methods of use thereof
CY1122800T1 (el) Συνθεσεις του παραγοντα viii και μεθοδοι δημιουργιας και χρησης αυτων
EA201691004A1 (ru) Последовательность модифицированного эндолизина kz144
EA201990860A1 (ru) Рнк-направляемые модифицирующие нуклеиновые кислоты ферменты и способы их применения
EA201691111A1 (ru) Химерные белки фактора viii и их применение
MY176331A (en) Carbohydrate degrading polypeptide and uses thereof
EA201892561A1 (ru) Гибридные белки gdf15 и их применение
BR112017015567A2 (pt) proteína gl de citomegalovírus recombinante ou fragmento de formação de complexo da mesma, complexo de citomegalovírus, ácido nucleico isolado, célula hospedeira, e, composição imunogênica
MX2023001119A (es) Variantes de enzimas y polinucleotidos que las codifican.
EA201171220A1 (ru) Мутанты fgf21 и их применение
BR112017019625A2 (pt) udp-glicosiltransferases
EA201190326A1 (ru) Полипептиды гормона роста и способы их получения и применения
PE20161442A1 (es) Proteinas quimericas tipo fosfatasa alcalina
MX2014011459A (es) Proteinas nutritivas cargadas y metodos.
WO2013040093A3 (en) Glucagon-like peptide-2 compositions and methods of making and using same
EA201401211A1 (ru) Улучшенные варианты фермента химозина
MX2021010668A (es) Proteinas de fusion de citoquinas.
EA201491643A1 (ru) Идентификация мутаций канал-опсина-2 (chop2) и способы применения
EA201890914A1 (ru) Доставка белка бактериями
MX2011004483A (es) Leucolectinas y sus usos.
EA201691981A1 (ru) Улучшенные транспортные молекулы модулярного антигена и их применение
NZ706884A (en) Fc gamma receptor iib variants
WO2016130628A8 (en) Griffithsin mutants
MX2018003850A (es) Moleculas de transporte de antigeno modular mejoradas y sus usos en animales.